← Back
Data updated: Mar 10, 2026
ROBINS AH
CardiovascularGastroenterology
ROBINS AH is a major pharmaceutical company focused on Cardiovascular, Gastroenterology.
1960
Since
10
Drugs
-
Trials
6
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
ROBINUL 2026-02-24
Labeling
REGLAN 2026-02-09
Labeling
REGLAN 2026-02-09
Labeling
ROBINUL 2025-09-25
Manufacturing (CMC)
ROBINUL 2025-07-16
Efficacy
ROBINUL 2024-07-12
Manufacturing (CMC)
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 50%
1 drugs
Gastroenterology 50%
1 drugs
Pipeline Strength Pro
Loading...
Discontinued (8)
Company Info
- First Approval
- 1960-04-15
- Latest
- 2004-02-10
- Applications
- 10